Related Experiment Video
Updated: Jun 15, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Fatty Liver Disease Along Cushing Syndrome Evolution.
Maria Marengo1, Claire Briet1,2, Mathilde Munier1,2,3
1Department of Endocrinology, Diabetology and Nutrition, Angers University Hospital, 49100 Angers, France.
Cushing syndrome often presents with metabolic syndrome and hepatic steatosis. This study found 26.5% of patients had metabolic dysfunction-associated steatotic liver disease (MASLD) at diagnosis, linked to diabetes and high triglycerides.
Area of Science:
- Endocrinology
- Hepatology
- Metabolic Syndrome
Background:
- Cushing syndrome frequently co-occurs with metabolic syndrome.
- Metabolic syndrome is strongly linked to hepatic steatosis, a key component of metabolic dysfunction-associated steatotic liver disease (MASLD).
Purpose of the Study:
- To determine the prevalence of MASLD at the time of Cushing syndrome diagnosis.
- To investigate the association between metabolic factors and MASLD in Cushing syndrome patients.
Main Methods:
- Retrospective single-center study of 49 Cushing syndrome patients with abdominal imaging.
- Hepatic steatosis diagnosed via liver/spleen density ratio on CT scan.
- Fibrosis predictive scores (FIB-4, NAFLD Fibrosis Score, eLIFT) calculated for patients with steatosis.
Main Results:
- Hepatic steatosis, diagnosed as MASLD, was present in 13 (26.5%) patients at Cushing syndrome diagnosis.
- MASLD patients exhibited higher rates of type 2 diabetes and elevated triglycerides.
- Two patients (15.4%) with MASLD showed scores predictive of significant fibrosis; 3/4 experienced steatosis remission after Cushing syndrome treatment.
Conclusions:
- The prevalence of hepatic steatosis (MASLD) at Cushing syndrome diagnosis is estimated at 26.5%.
- Metabolic factors are significantly associated with the development of hepatic steatosis in Cushing syndrome.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Obesity
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

